Stocks Hitting 52-Week Lows

The Medicines Company

shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation. NephroGenex

shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share. Bio-Path Holdings

shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period. Akers Biosciences

shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.